← Back to Clinical Trials
Recruiting NCT06524869

NCT06524869 Association Between Neuromuscular Parameters and Functional Assessment After ACL Reconstruction

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06524869
Status Recruiting
Phase
Sponsor University Hospital, Caen
Condition ACL Injury
Study Type OBSERVATIONAL
Enrollment 25 participants
Start Date 2024-03-10
Primary Completion 2024-07-24

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 40 Years
Study Type OBSERVATIONAL
Interventions
Isokinetic neuromuscular assessment

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 25 participants in total. It began in 2024-03-10 with a primary completion date of 2024-07-24.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The anterior cruciate ligament (ACL) injury is common in athletes aged 18 to 35. ACL reconstruction (ACLR) aims to restore knee stability in the process of returning to sports. Post-surgical rehabilitation focuses on optimizing biomechanical parameters, with neuromuscular and functional tests assessing muscle strength, proprioception, and dynamic stability. Isokinetic allows the measurement of muscle strength symmetry and proprioception, while the single-leg hop and landing tasks assess functional stability and are predictive of sports resumption and injury prevention. Despite progress, concerns remain about neuromuscular factors impacting knee stability, especially during landings, which can increase the risk of secondary ACL injuries. This study proposes examining knee strength and proprioception using isokinetic dynamometry, alongside biomechanical assessments from functional tests, to explore their relationship to biomechanical features during landings, at 6-to-12 months post-ACL reconstruction. The hypothesis is that better muscle strength and proprioception correlate with improved knee control during landing tasks.

Eligibility Criteria

Inclusion Criteria: * Adult patients, aged 18-40, who have undergone a first ACL reconstruction more than 6 months ago and are being followed in a sports medicine care pathway * Affiliated with a health insurance plan * Information form: Non-objection to the use of data for research purposes Exclusion Criteria: * Previous ligament surgery of the lower limbs prior to ACL reconstruction * Complex ligament injury (lateral ligaments, posterior cruciate ligament) * Recent muscle injuries * History of injury to the uninjured knee * Pregnant woman * Neurological history with residual effects or taking medication that affects balance/coordination * Inability to perform a muscular assessment * Postoperative complications (deep vein thrombosis, sepsis, stiffness/arthrofibrosis)

Frequently Asked Questions

Who can join the NCT06524869 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 40 Years, studying ACL Injury. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06524869 currently recruiting?

Yes, NCT06524869 is actively recruiting participants. Visit ClinicalTrials.gov or contact University Hospital, Caen to inquire about joining.

Where is the NCT06524869 trial being conducted?

This trial is being conducted at Caen, France.

Who is sponsoring the NCT06524869 clinical trial?

NCT06524869 is sponsored by University Hospital, Caen. The trial plans to enroll 25 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology